Hatim Husain
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NCT04043195) | Hatim Husain | 2019-08-14 |
Track Hatim Husain automatically
Every clearance here is in the API, with alerts when new ones post.